Oncology Therapeutics and Drug Development
JODD
- URL: https://www.globalmeetx.com/journals/jodd
- Call For Paper Type: Regular
- H2 Index: 0
Hematology Immunology Oncology
Advancing Innovation in Cancer Drug Discovery and Therapy.
Oncology Therapeutics and Drug Development is a multidisciplinary, peer-reviewed journal dedicated to advancing innovation in cancer therapy and pharmaceutical research. The journal provides a global platform for publishing high-impact studies on the discovery, design, and clinical translation of next-generation anticancer agents. It covers the full oncology drug development pipeline, from target identification and preclinical research to clinical trials and therapeutic optimization. The journal welcomes original research, reviews, and translational studies in small molecules, biologics, targeted therapies, and immuno-oncology. Key focus areas include antibody-drug conjugates, gene and cell-based therapies, and rational combination strategies. Strong emphasis is placed on precision oncology, biomarker-guided treatment, and personalized medicine. Emerging technologies such as nanomedicine, advanced drug delivery, and AI-driven drug discovery are highly encouraged. The journal also features studies on pharmacokinetics, pharmacodynamics, toxicity, and resistance mechanisms. By bridging laboratory research and clinical practice, the journal promotes rapid scientific translation. It brings together researchers, clinicians, and industry professionals worldwide. Committed to ethical publishing and scientific rigor, the journal supports global research visibility. Oncology Therapeutics and Drug Development aims to accelerate safer, more effective, patient-centered cancer therapies.
Aim and Scope
Oncology Therapeutics and Drug Development aims to advance cutting-edge research that drives innovation in cancer treatment and pharmaceutical development. The journal provides a global platform for the discovery, development, and clinical translation of novel anticancer therapeutics. It covers the complete oncology drug development continuum, from target identification and preclinical evaluation to clinical trials and therapeutic optimization. The journal publishes high-quality original research, reviews, and translational studies. Core areas include small molecules, biologics, targeted therapies, immunotherapies, and antibody-drug conjugates. Special emphasis is placed on precision oncology and biomarker-driven treatment strategies. The journal encourages research on gene and cell-based therapies and rational combination approaches. Emerging technologies such as nanomedicine, advanced drug delivery, and AI-driven drug design are strongly welcomed. Studies on pharmacokinetics, pharmacodynamics, toxicity, and resistance mechanisms are highly encouraged. By integrating academic, clinical, and industrial perspectives, the journal accelerates therapeutic innovation. The ultimate aim is to support the development of safer, more effective, and patient-centered cancer therapies worldwide.
Submission Details:
📅 Submissions Open: Accepting manuscripts for upcoming issues
📱 WhatsApp: +44 7897 072181
📧 Email: cancerjournal@globalmeetx.net
Submit your manuscript today and contribute to the future of cancer therapeutics.
Event Promotion
|
|
The 13th International Conference on Quantum Dots (QD 2026) |
| 2026-05-17 ~ 2026-05-22 |
|
|
The 22nd International Symposium on the Physics of Semiconductors and Applications (ISPSA 2026) |
| 2026-06-28 ~ 2026-07-02 |
|
|
The 15th Asia-Pacific Conference on Transportation and the Environment (APTE 2026) |
| 2026-07-08 ~ 2026-07-10 |
MANUSCRIPTLINK © 2015 -
